Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30 Recalled by Biomerieux Inc Due to As the temperature and time out of range...

Date: November 9, 2022
Company: Biomerieux Inc
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Biomerieux Inc directly.

Affected Products

ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927

Quantity: 2 units

Why Was This Recalled?

As the temperature and time out of range was exceeded, product performances cannot be guaranteed

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Biomerieux Inc

Biomerieux Inc has 368 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report